Appili Therapeutics Inc. APLI.TO Stock
Appili Therapeutics Inc. Price Chart
Appili Therapeutics Inc. APLI.TO Financial and Trading Overview
| Appili Therapeutics Inc. stock price | 0.05 CAD |
| Previous Close | 0.04 CAD |
| Open | 0.04 CAD |
| Bid | 0.03 CAD x N/A |
| Ask | 0.04 CAD x N/A |
| Day's Range | 0.04 - 0.04 CAD |
| 52 Week Range | 0.03 - 0.08 CAD |
| Volume | 22K CAD |
| Avg. Volume | 71.07K CAD |
| Market Cap | 4.24M CAD |
| Beta (5Y Monthly) | 1.015964 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.04 CAD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 0.2 CAD |
APLI.TO Valuation Measures
| Enterprise Value | 8.26M CAD |
| Trailing P/E | N/A |
| Forward P/E | -0.5 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | Infinity |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -1.094 |
Trading Information
Appili Therapeutics Inc. Stock Price History
| Beta (5Y Monthly) | 1.015964 |
| 52-Week Change | -50.00000000000000000000000000000000% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.08 CAD |
| 52 Week Low | 0.03 CAD |
| 50-Day Moving Average | 0.04 CAD |
| 200-Day Moving Average | 0.05 CAD |
APLI.TO Share Statistics
| Avg. Volume (3 month) | 71.07K CAD |
| Avg. Daily Volume (10-Days) | 44.7K CAD |
| Shares Outstanding | 121.27M |
| Float | 91.75M |
| Short Ratio | 0.79 |
| % Held by Insiders | 12.43% |
| % Held by Institutions | 12.03% |
| Shares Short | 82.8K |
| Short % of Float | N/A |
| Short % of Shares Outstanding | 0.069% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | March 31, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | March 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 100.00% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -67.70% |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | 0 CAD |
| Revenue Per Share (ttm) | 0 CAD |
| Quarterly Revenue Growth (yoy) | -99.29% |
| Gross Profit (ttm) | 1.39M CAD |
| EBITDA | -7547579 CAD |
| Net Income Avi to Common (ttm) | -9915818 CAD |
| Diluted EPS (ttm) | -0.11 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 1.43M CAD |
| Total Cash Per Share (mrq) | 0.01 CAD |
| Total Debt (mrq) | 5.44M CAD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 0.988 |
| Book Value Per Share (mrq) | -0.044 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -12852020 CAD |
| Levered Free Cash Flow (ttm) | -10369862 CAD |
Profile of Appili Therapeutics Inc.
| Country | Canada |
| State | NS |
| City | Halifax |
| Address | #21-1344 Summer Street |
| ZIP | B3H 0A8 |
| Phone | N/A |
| Website | https://www.appilitherapeutics.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 8 |
Appili Therapeutics Inc., a biopharmaceutical company, focuses on the acquisition and development of novel medicines for unmet needs in the infectious disease in Canada. Its anti-infective portfolio includes Favipiravir for pandemic influenza and COVID-19; ATI-2307, an antifungal candidate, which is in clinical stage for the treatment of cryptococcal meningitis and invasive candidiasis; ATI-1503 that develops a class of gram-negative targeting antibiotics; ATI-1501, a taste-masked liquid oral suspension formulation of an antibiotic, metronidazole; ATI-1801, a novel topical formulation of paromomycin for the treatment of cutaneous leishmaniasis; and ATI-1701 is a live-attenuated vaccine for Francisella tularensis. The company has a strategic alliance with AiPharma Global Holdings LLC for the development of Avigan/Reeqonus (favipiravir). Appili Therapeutics Inc. was incorporated in 2015 and is headquartered in Halifax, Canada.
Q&A For Appili Therapeutics Inc. Stock
What is a current APLI.TO stock price?
Appili Therapeutics Inc. APLI.TO stock price today per share is 0.05 CAD.
How to purchase Appili Therapeutics Inc. stock?
You can buy APLI.TO shares on the Toronto exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Appili Therapeutics Inc.?
The stock symbol or ticker of Appili Therapeutics Inc. is APLI.TO.
Which industry does the Appili Therapeutics Inc. company belong to?
The Appili Therapeutics Inc. industry is Biotechnology.
How many shares does Appili Therapeutics Inc. have in circulation?
The max supply of Appili Therapeutics Inc. shares is 121.27M.
What is Appili Therapeutics Inc. Price to Earnings Ratio (PE Ratio)?
Appili Therapeutics Inc. PE Ratio is now.
What was Appili Therapeutics Inc. earnings per share over the trailing 12 months (TTM)?
Appili Therapeutics Inc. EPS is -0.04 CAD over the trailing 12 months.
Which sector does the Appili Therapeutics Inc. company belong to?
The Appili Therapeutics Inc. sector is Healthcare.